Literature DB >> 12566321

We need Romanow's National Drug Agency.

.   

Abstract

Mesh：

Year:  2003        PMID： 12566321      PMCID： PMC140458     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Some natural skepticism about the Natural Health Products Directorate.

Authors: 
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

2.  Postmarketing drug surveillance: what it would take to make it work.

Authors: 
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

3.  Lessons from cisapride.

Authors: 
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

Review 4.  Alosetron: a case study in regulatory capture, or a victory for patients' rights?

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2002-09-14
  4 in total
  3 in total

1.  A national drug agency.

Authors:  Roy West; E Keith Borden; Jean-Paul Collet; Nigel S B Rawson; Robert S Tonks
Journal:  CMAJ       Date:  2003-04-15       Impact factor: 8.262

2.  Prescription drug expenditures rising--too fast?

Authors: 
Journal:  CMAJ       Date:  2005-05-10       Impact factor: 8.262

3.  A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.

Authors:  Steven G Morgan; Marc-André Gagnon; Barbara Mintzes; Joel Lexchin
Journal:  Healthc Policy       Date:  2016-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.